These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11516960)

  • 1. A novel family of predicted retroviral-like aspartyl proteases with a possible key role in eukaryotic cell cycle control.
    Krylov DM; Koonin EV
    Curr Biol; 2001 Aug; 11(15):R584-7. PubMed ID: 11516960
    [No Abstract]   [Full Text] [Related]  

  • 2. Ddi1, a eukaryotic protein with the retroviral protease fold.
    Sirkis R; Gerst JE; Fass D
    J Mol Biol; 2006 Dec; 364(3):376-87. PubMed ID: 17010377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation.
    Matsui T; Kinoshita-Ida Y; Hayashi-Kisumi F; Hata M; Matsubara K; Chiba M; Katahira-Tayama S; Morita K; Miyachi Y; Tsukita S
    J Biol Chem; 2006 Sep; 281(37):27512-25. PubMed ID: 16837463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionarily conserved functional mechanics across pepsin-like and retroviral aspartic proteases.
    Cascella M; Micheletti C; Rothlisberger U; Carloni P
    J Am Chem Soc; 2005 Mar; 127(11):3734-42. PubMed ID: 15771507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the sequences, 3-D structures and mechanisms of pepsin-like and retroviral aspartic proteinases.
    Blundell TL; Cooper JB; Sali A; Zhu ZY
    Adv Exp Med Biol; 1991; 306():443-53. PubMed ID: 1812741
    [No Abstract]   [Full Text] [Related]  

  • 6. A family of aspartic proteases and a novel, dynamic and cell-cycle-dependent protease localization in the secretory pathway of Toxoplasma gondii.
    Shea M; Jäkle U; Liu Q; Berry C; Joiner KA; Soldati-Favre D
    Traffic; 2007 Aug; 8(8):1018-34. PubMed ID: 17547703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermis.
    Bernard D; Méhul B; Thomas-Collignon A; Delattre C; Donovan M; Schmidt R
    J Invest Dermatol; 2005 Aug; 125(2):278-87. PubMed ID: 16098038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel conserved domains in proteins with predicted roles in eukaryotic cell-cycle regulation, decapping and RNA stability.
    Anantharaman V; Aravind L
    BMC Genomics; 2004 Jul; 5(1):45. PubMed ID: 15257761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
    Ringe D
    Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationships of human immunodeficiency virus protease with eukaryotic aspartic proteases.
    Lin XL; Lin YZ; Tang J
    Methods Enzymol; 1994; 241():195-224. PubMed ID: 7854179
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases.
    Steiner H; Kostka M; Romig H; Basset G; Pesold B; Hardy J; Capell A; Meyn L; Grim ML; Baumeister R; Fechteler K; Haass C
    Nat Cell Biol; 2000 Nov; 2(11):848-51. PubMed ID: 11056541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis.
    Culberson JC; Bush BL; Sardana VV
    Methods Enzymol; 1994; 241():385-94. PubMed ID: 7854190
    [No Abstract]   [Full Text] [Related]  

  • 13. Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases.
    Rao JK; Erickson JW; Wlodawer A
    Biochemistry; 1991 May; 30(19):4663-71. PubMed ID: 1851433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of Saccharomyces cerevisiae yapsin 3, a new member of the yapsin family of aspartic proteases encoded by the YPS3 gene.
    Olsen V; Cawley NX; Brandt J; Egel-Mitani M; Loh YP
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):407-11. PubMed ID: 10191273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation.
    Davis DA; Brown CA; Newcomb FM; Boja ES; Fales HM; Kaufman J; Stahl SJ; Wingfield P; Yarchoan R
    J Virol; 2003 Mar; 77(5):3319-25. PubMed ID: 12584357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a glutamine residue essential for catalytic activity of aspergilloglutamic peptidase by site-directed mutagenesis.
    Yabuki Y; Kubota K; Kojima M; Inoue H; Takahashi K
    FEBS Lett; 2004 Jul; 569(1-3):161-4. PubMed ID: 15225626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal domain of pepsin as a model for retroviral dimeric aspartyl protease.
    Bianchi M; Boigegrain RA; Castro B; Coletti-Previero MA
    Biochem Biophys Res Commun; 1990 Feb; 167(1):339-44. PubMed ID: 2106884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a gene from the filamentous fungus Podospora anserina encoding an aspartyl protease induced upon carbon starvation.
    Paoletti M; Clavé C; Bégueret J
    Gene; 1998 Mar; 210(1):45-52. PubMed ID: 9524217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG; Heinrikson RL
    Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
    [No Abstract]   [Full Text] [Related]  

  • 20. Fungal yapsins and cell wall: a unique family of aspartic peptidases for a distinctive cellular function.
    Gagnon-Arsenault I; Tremblay J; Bourbonnais Y
    FEMS Yeast Res; 2006 Nov; 6(7):966-78. PubMed ID: 17042746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.